Company

ClearPoint Neuro, Inc.

Headquarters: Irvine, CA, United States

Employees: 49

CEO: Mr. Joseph Michael Burnett

NASDAQ: CLPT +6.07%

Market Cap

$149.2 Million

USD as of July 1, 2024

Market Cap History

ClearPoint Neuro, Inc. market capitalization over time

Evolution of ClearPoint Neuro, Inc. market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of ClearPoint Neuro, Inc.

Detailed Description

ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain stimulation electrodes and biopsy needles, and the infusion of pharmaceuticals and laser catheters into the brain; and ClearPoint Neuro Navigation System, an MRI suite. It has license and collaboration agreements with Boston Scientific Corporation, The Johns Hopkins University, Clinical Laserthermia Systems Americas Inc, Koninklijke Philips N.V., Blackrock Neurotech, and University of California and San Francisco. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Stocks & Indices

ClearPoint Neuro, Inc. has the following listings and related stock indices.


Stock: NASDAQ: CLPT wb_incandescent

Details

Headquarters:

5 Musick

Irvine, CA 92618

United States

Phone: 949 900 6833

Fax: 949 900 6834